Journey Medical Corporation (DERM)
NASDAQ: DERM · IEX Real-Time Price · USD
3.450
-0.170 (-4.70%)
May 17, 2024, 4:30 PM EDT - Market closed
Journey Medical Revenue
Journey Medical had revenue of $80.00M in the twelve months ending March 31, 2024, with 27.82% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $13.03M with 6.69% year-over-year growth. In the year 2023, Journey Medical had annual revenue of $79.18M with 7.48% growth.
Revenue (ttm)
$80.00M
Revenue Growth
+27.82%
P/S Ratio
0.88
Revenue / Employee
$1,951,171
Employees
41
Market Cap
70.25M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 79.18M | 5.51M | 7.48% |
Dec 31, 2022 | 73.67M | 10.54M | 16.69% |
Dec 31, 2021 | 63.13M | 18.60M | 41.78% |
Dec 31, 2020 | 44.53M | 9.61M | 27.52% |
Dec 31, 2019 | 34.92M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
P3 Health Partners | 1.35B |
Personalis | 74.15M |
Neuronetics | 73.23M |
Bionano Genomics | 37.47M |
Cryo-Cell International | 31.37M |
Marinus Pharmaceuticals | 28.29M |
Prenetics Global | 21.74M |
CollPlant Biotechnologies | 10.96M |
DERM News
- 3 days ago - Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase - GlobeNewsWire
- 5 days ago - Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 11 days ago - Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024 - GlobeNewsWire
- 17 days ago - Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer - GlobeNewsWire
- 23 days ago - Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024 - GlobeNewsWire
- 2 months ago - Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea - GlobeNewsWire
- 2 months ago - Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 - GlobeNewsWire